This website uses cookies to improve your experience. You can accept or reject analytics cookies
Influenza Pandemic Preparedness And Response Plan
Pandemic Preparedness and ResponseNational Control Plan2006
JamaicaEnglishPDF
National
AI-Generated Document Summary
Objectives
Jamaica’s influenza pandemic preparedness and response plan provides a comprehensive health-sector framework for preventing, mitigating, preparing for and responding to avian and pandemic influenza, while defining supporting roles for other ministries, agencies, essential services and private-sector partners. It applies across World Health Organization pandemic phases, from inter-pandemic preparedness through pandemic response, recovery, deactivation, debriefing and final reporting.
Strengthen surveillance, laboratory capacity and international links to detect emerging influenza threats early, define their epidemiology and assess risks continuously.
Delay virus entry, contain transmission, reduce morbidity and mortality, and limit social, health-system and economic disruption through public-health, clinical, pharmaceutical and social measures.
Develop nationally coordinated contingency plans, rapid resource-mobilisation arrangements, stockpiles, surge capacity and trained workforces for national, regional, parish, institutional and community response.
Organise action around planning and coordination; situation monitoring and assessment; prevention and containment; health-system response; and communications.
Implement prevention measures including public education, workforce training, sector-specific guidance, protocols for contaminated materials, monitoring of relevant industries, and quarantine and public-health legislation.
Prepare vaccine and antiviral policies, including prioritisation, stockpile requirements, procurement and deployment arrangements, while monitoring vaccine and prophylaxis development.
Maintain transparent, timely information for the public, health workers, government bodies, media and service providers, including advice that addresses uncertainty, anxiety, misinformation and stigma.
Support post-pandemic recovery by reviewing lessons, restoring essential services, replenishing supplies, addressing psychological impacts and revising plans for subsequent waves.
Implementation
The Ministry of Health leads the national response, working closely with other ministries, agencies, health services, veterinary authorities, disaster-management bodies, international organisations and non-governmental and private-sector partners. World Health Organization phase declarations trigger corresponding national action, while national subdivisions and operational priorities are determined through ongoing risk assessment and technical consultation.
Coordinate multisectoral planning with agriculture, transport, trade, labour, defence, education, port health, immigration, tourism, industry and essential-service providers, with particular emphasis on collaboration with the Ministry of Agriculture to address animal-to-human influenza risks.
Activate the plan through the Chief Medical Officer or designated senior health leadership after consultation with the Permanent Secretary and Minister of Health; notify the National Disaster Executive and relevant ministries and agencies after activation.
Operate the Ministry of Health National Emergency Operations Centre on a full 24-hour basis in Phase 6, and use graduated operational levels during Phases 3 to 5 according to whether Jamaica is affected.
Activate regional, parish, institutional and community plans alongside the national plan, with response actions directed through the Ministry of Health Disaster Executive and Emergency Operations Centre.
Establish screening, triage, isolation, quarantine, laboratory, mortuary and infection-control arrangements; distribute case definitions, patient-management protocols and technical guidance; and prepare facilities for surge demand and alternative care delivery.
Train health workers, outbreak responders and personnel in exposed sectors; maintain workforce rosters; protect responders through personal protective equipment and possible antiviral deployment; and prepare staffing, volunteer and staff-support arrangements.
Conduct enhanced human and animal surveillance, field investigations, laboratory confirmation, virus characterisation and information-sharing with the World Health Organization, Pan American Health Organization, Food and Agriculture Organization and World Organisation for Animal Health.
Require immediate notification of suspected avian influenza and reporting within 24 hours of diagnosis, using notification chains that link clinicians, hospitals, parish and regional authorities, national surveillance functions and port quarantine officers.
Use simulation exercises, drills, checklist reviews, audits and monitoring visits to test contingency plans, command arrangements, health-facility readiness, infection control and communication capacity.
Monitor disease spread, clinical and virological characteristics, morbidity and mortality, resource availability, hospital capacity, workforce availability, vaccine and antiviral performance, antiviral resistance and the effects of public-health measures.
Adjust surveillance from intensive case-based and virological monitoring to aggregate morbidity and mortality monitoring when activity becomes widespread, while retaining sufficient virological surveillance to detect antigenic change.
Deactivate the response once control and follow-up actions are complete and incidence returns to determined endemic levels; hold institutional, parish, regional and Ministry of Health debriefings, then prepare a final report within the specified post-deactivation timelines.
Monitoring & Evaluation
The plan establishes a phase-based monitoring, surveillance, reporting and review system for influenza pandemic preparedness, response, recovery and deactivation. It combines human and animal surveillance, laboratory investigation, continuous risk assessment, health-system monitoring, international information-sharing, exercises, audits, debriefings and a final report.
Maintain surveillance for early detection, ongoing epidemiological assessment and identification of human and animal infections with new influenza strains, clusters of influenza-like illness, respiratory deaths, sources of infection and transmission risks.
Classify avian and pandemic influenza as Class 1 notifiable diseases, requiring immediate reporting of suspected cases and reporting within 24 hours of diagnosis; during later alert phases, report suspected cases to epidemiology within 24 hours and confirmations as soon as possible.
Apply notification chains involving clinicians, hospital managers, parish Medical Officers of Health, regional and national health authorities, surveillance functions and port quarantine officers.
Strengthen laboratory monitoring through diagnostic criteria, safe specimen handling and transport, characterisation and sharing of virus isolates, pathogenicity testing, virological surveillance, serological surveillance of exposed workers, and collaboration with designated reference laboratories and international agencies.
Conduct continuous risk assessment to guide national phase subdivisions, prioritise actions and assess pathogenicity, transmission rates, geographical spread, illness severity, clinical features and viral-genome information.
Monitor vaccine and prophylaxis development, antiviral resistance, pharmaceutical and diagnostic requirements, and the availability of vaccines, medical supplies, infrastructure, hospital beds, staff, alternative care facilities and mortuary capacity.
Track disease spread, morbidity, mortality, absenteeism, affected regions and risk groups, service pressures, health-care and essential-worker availability, admissions and national pandemic impacts.
Adapt surveillance as transmission intensifies, including a possible shift from intensive case-based and virological surveillance to aggregate morbidity and mortality monitoring while retaining enough virological surveillance to identify antigenic drift.
Report routine and unusual findings nationally and internationally, including through the World Health Organization, Pan American Health Organization, Food and Agriculture Organization and World Organisation for Animal Health; Phase 5 also requires reporting increased spread under the revised International Health Regulations as a public health emergency of international concern.
Maintain regular information-sharing with health authorities, government bodies, service providers, media organisations, the public and international partners, including transparent communication of known and uncertain aspects of an outbreak.
Review preparedness using the World Health Organization influenza pandemic preparedness checklist, identify deficiencies and priority actions, and reassess plans against national planning tools as pandemic risk develops.
Test readiness through simulation exercises, drills and table-top exercises covering contingency plans, command-and-control arrangements, decision-making, communication capacity, health-facility preparedness and surge arrangements.
Undertake audits and monitoring visits at hospitals and special isolation facilities, with attention to infection-control implementation, laboratory biosafety and operational capacity.
Evaluate response measures by assessing public-health interventions, treatment protocols, non-pharmaceutical measures, vaccine uptake, safety and efficacy, antiviral use and resistance, prophylaxis outcomes, clinical interventions and communication activities.
Assign monitoring and response responsibilities to named Ministry of Health officials, divisions, regional and hospital personnel, laboratories and partner institutions, although the excerpts do not set out a separate formal accountability framework or quantitative performance targets.
Deactivate the response after transmission-control and follow-up actions are complete and incidence has returned to determined endemic levels, on declaration by the Chief Medical Officer or designated senior health leadership.
Hold institutional, parish and regional debriefings before the Ministry of Health debrief; submit reports at least three days in advance; convene the Ministry of Health debrief within seven working days of deactivation; and prepare the final report within fourteen working days of deactivation and ten working days of the debriefing.
Quantitative indicators, routine reporting frequencies, formal evaluation criteria and audit standards are generally not specified. The principal explicit time-bound reporting requirements concern immediate notification, reporting within 24 hours of diagnosis, reporting suspected cases within 24 hours during alert phases, and the post-deactivation debriefing and final-report timetable.
Costing & Financing
The plan identifies substantial preparedness and response resource requirements, but does not provide a costed budget, expenditure totals, financing allocations, funding sources, funding-gap estimates, costing methodology or economic assumptions.
Prepare a needs list and budget for pandemic preparedness activities.
Mobilise and deploy additional resources rapidly to priority areas during an emerging threat, pandemic alert or response.
Develop and maintain national stockpile requirements for antivirals, vaccines, personal protective equipment, laboratory diagnostics, reagents, pharmaceuticals, emergency materials, equipment, furniture and other supplies.
Estimate pharmaceutical and material requirements, secure supplies and make risk-based decisions on maintaining, deploying or relocating national and global stockpile resources.
Plan facility upgrades, screening, triage, quarantine and isolation capacity, alternative care arrangements, workforce rosters, staff deployment and surge capacity for essential workers and health services.
Monitor finite resources in Phase 5 and Phase 6, including medical supplies, pharmaceuticals, infrastructure, vaccines, hospital capacity, human resources and the sustainability of health-system delivery.
Procure and deliver pandemic vaccines as supplies and resources permit, while monitoring supply, evaluating safety and efficacy, and reviewing antiviral distribution and use.
Provide drugs and medical care at no cost to patients and the health-care system as an operational measure intended to encourage prompt reporting of new cases.
Establish a compensation policy for animals lost through culling, without specifying an allocation, payment level or financing mechanism.
Replenish medicines and supplies, service essential equipment, support staff recovery and rebuild essential services after the pandemic or between waves.
Assess pandemic resource needs and, where resources permit, forecast the economic impact of the pandemic; no economic estimates or assumptions are supplied.
The plan refers to possible emergency powers, international assistance needs and procedures to obtain additional resources, but it does not identify committed domestic or external financing sources or quantify any resource shortfall.